Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survival Outcome Analysis on the Strategy Shift Integrating a Multimodal Therapy of Neoadjuvant Chemotherapy and Extended Pancreatectomy in Pancreatic Cancer: A Clinical Study From a Retrospective Cohort in a Single Institute

NCT06938906 is registered in ClinicalTrials.gov with National Cheng Kung University as lead sponsor.

NCT NCT06938906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06938906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survival Outcome Analysis on the Strategy Shift Integrating a Multimodal Therapy of Neoadjuvant Chemotherapy and Extended Pancreatectomy in Pancreatic Cancer: A Clinical Study From a Retrospective Cohort in a Single Institute
Lead sponsor
National Cheng Kung University
Phase
Observational
Overall status
Active, not recruiting
Start date
January 3, 2011
Completion date
April 30, 2025
Enrollment
405 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoadjuvant chemotherapy, pancreatectomy, pancreatic cancer